On Cancer

and/or

22 Blog posts found

In the Lab

Scientists Create First-of-Its-Kind Metabolic Road Map of Cancer

The online resource will serve as a benchmark for researchers studying metabolism and cancer.

abstract red and blue lines suggestive of metabolic pathways

Announcement

Three Investigators Named Winners of the 2017 Paul Marks Prize for Cancer Research

Memorial Sloan Kettering has named three winners of this year’s Paul Marks Prize for Cancer Research, an award that recognizes promising early-career investigators.

Aviv Regev of the Broad Institute and the Massachusetts Institute of Technology

Announcement

FDA Authorizes MSK-IMPACT Test for Analyzing Patient Tumors

The test, developed at MSK, looks for alterations in 468 genes that are seen in both common and rare cancers.

Gloved hand and magnifying glass on banded DNA sequences

Making a Splash: Researchers Apply Face-Detection Technology to the Study of Genes

Taking a cue from smartphone technology, scientists are using face-recognition algorithms to improve RNA interference.

Mount Rushmore viewed through face-detection software.

In the Lab

A Cut Above: MSK-Developed Software Makes CRISPR More Precise

A freely accessible software program provides researchers with an easy way to optimize a popular genome-editing tool.

An illustration of CRISPR-Cas9

In the Clinic

Powerful Tumor DNA Test Has Guided Cancer Treatment for 10,000 MSK Patients

Learn how MSK’s powerful new tumor DNA test has helped guide treatment decisions for more than 10,000 people with advanced cancer.

Three scientists look up at ascreen showing genetic information about a tumor.

In the Lab

Project GENIE Aims to Make Sense of Vast Amounts of Genomic Data

A multi-institutional effort led by MSK’s Charles Sawyers is seeking to interpret information about the genetic causes of cancer.

Illustration of DNA strands

In the Lab

A Netflix-Inspired Approach to Understanding Biology and Medicine

Computers currently help us choose our favorite movies, books, and TV shows. Will personalized medicines be next?

Researchers at MSK have devised a technique, based on machine learning, that can predict the DNA binding preferences of a protein called a transcription factor.

Q&A

A Computational Biologist Explains How Cancer Patient Data Leads to Personalized Medicine

Researcher Barry Taylor discusses the importance of understanding the function of individual mutations found in patients’ tumors.

Barry Taylor sitting at a desk.

In the Lab

Study Provides New Clues about the Diversity of Prostate Cancer Subtypes

A multicenter study led by MSK investigators has found seven subtypes based on their molecular characteristics.